Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma

邢洁; 谢幸

doi:10.3969/j.issn.1007-3969.2014.12.009

您当前的位置：

首页 >

文章列表页 >

Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma

更新时间：2025-12-31

- Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma
- China Oncology Vol. 24, Issue 12, Pages: 931-935(2014)
- 作者机构：
  
  浙江省肿瘤医院肿瘤妇科,浙江,杭州,310022
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2014.12.009
  CLC：
- Published Online：07 May 2015，
  
  Published：07 May 2014
- 稿件说明：
移动端阅览
邢洁,谢幸,于爱军等. 早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析[J]. 中国癌症杂志, 2014, 24(12): 931-935.

邢洁, 谢幸. Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma[J]. China Oncology, 2014, 24(12): 931-935.
邢洁,谢幸,于爱军等. 早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析[J]. 中国癌症杂志, 2014, 24(12): 931-935. DOI： 10.3969/j.issn.1007-3969.2014.12.009.

邢洁, 谢幸. Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma[J]. China Oncology, 2014, 24(12): 931-935. DOI： 10.3969/j.issn.1007-3969.2014.12.009.

摘要

背景与目的：随着近年来子宫内膜癌在年轻人中发病率的上升，孕激素保守治疗受到关注。本研究探讨孕激素保守治疗年轻早期子宫内膜癌患者的效果及对预后的影响。方法：回顾性分析2002—2014年浙江省肿瘤医院及浙江大学附属妇产科医院共19例早期年轻子宫内膜癌患者激素治疗的相关资料。结果：19例患者中首次治疗完全缓解率为68.4%，复发率为15.4%，妊娠生育率为46.2%，平均随访时间为87.9个月。结论：激素治疗是有生育要求的早期子宫内膜癌患者实现妊娠的有效方案，但相比传统治疗方案存在一定的复发风险。

Abstract

Background and purpose: The morbidity rate of endometrial cancer is increasing in young patients these years. Fertility-sparing treatment with progesterone was concerned. The objective of this study was to evaluate the efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma. Methods: The data of 19 early endometrial cancer patients fertility-sparing treatment with progestin was reviewed. These patients were treated and followed up at Zhejiang Cancer Hospital and Zhejiang Women’s Hospital from 2002 to 2014. Results: After primary treatment

68.4% of patients achieved complete response. The recurrence rate was approximately 15.4% in a median follow-up period of 87.9 months

46.2% of the patients succeed in giving birth. Conclusion: Fertility-sparing treatment with progesterone is an effective method to preserve fertility for early endometrial cancer patients. But it has inherent risks

comparing with the traditional treatment.

关键词

Keywords

references

Views

2839

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Synchronous primary fallopian tube and endometrial cancers: a report of three cases and literature review

Effects of a small interfering RNA targeting CDK4 gene on the biological functions of endometrial cancer cells

Effects of PTEN on the migration and invasion of endometrial carcinoma cells

Related Author

包灵洁

宁　燕

易晓芳

常军

刘玲芳

郑殊娟

张婵

李云云

Related Institution

复旦大学附属妇产科医院妇科

复旦大学附属妇产科医院病理科

四川省妇幼保健院妇科

重庆市第三人民医院妇产科

南昌大学附属第二医院江西省医学分子重点实验室

AI问答

⁰